Frank Kung
National Tsing Hua University
Tell me more about Frank Kung?
Frank Kung is a founding member of Vivo Ventures, LLC, a healthcare/biotechnology venture capital management firm in Palo Alto, California. He has over 44 years of experience in the biotechnology industry, including co-founding Cetus Corporation and Genelabs Technologies, Inc. He has also served as Chairman and CEO of Genelabs, bringing the company public to a large biotech company with operations in the United States, Belgium, Singapore, Switzerland, and Taiwan. Dr. Kung holds a B.S. in chemistry from the National Tsing Hua University and a Ph.D. in molecular biology from the University of California, Berkeley. He is currently serving on the board of directors of various emerging healthcare
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Dr. Kung is a founding member of Vivo Ventures, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California. Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation. He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983. In 1984 he co-founded Genelabs Technologies, Inc. (NADSAQ: GNLB) where he served as Chairman and CEO until 1995. During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan. Dr. Kung received his B.S. in chemistry from the National Tsing Hua University in Taiwan, his Ph.D. in molecular biology and M.B.A. from the University of California, Berkeley. He received the Best Use of Technology Award from the Governor of California, the Entrepreneur of the Year Awards from Ernst and Young, and the Asian Business League. He also served on the board of directors of the Emerging Company Governing Body of the Biotechnology Industry Organization (BIO); Mt. Jade Science and Technology Association, West Coast; and the Asian American Manufacturing Association. He was appointed by the U.S. Secretary of Health and Human Services as a voting member of the National Biotechnology Policy Board. Dr. Kung currently serves on the board of directors of a number of emerging healthcare and biotechnology companies. Dr. Kung is a founding member of Vivo Ventures, LLC. Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation. He later co-founded Cetus Immune Corporation which was acquired by its parent company in 1983. In 1984 he co-founded Genelabs Technologies, Inc. (NADSAQ:GNLB) where he served as Chairman and CEO until 1995. During his tenure in Genelabs, he brought the company public and built it to an international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan. Dr. Kung received the Best Use of Technology Award from the Governor of California, the Entrepreneur of the Year Awards from Ernst and Young, and the Asian Business League. He was also appointed by the U.S. Secretary of Health and Human Services as a voting member of the National Biotechnology Policy Board.
...See MoreWork Experience
Frank Kung's Professional Milestones
- Managing Partner: Driving strategic initiatives, fostering collaboration, and improving business performance through effective business strategies.
- Founding Member: Successfully established a successful organization, expanding our reach and fostering a positive impact.
Education
Chemistry,
Bs
Certification
Colleagues
Other Named Frank Kung
Frequently asked questions
We found 2 Frank Kung's email addresses
Frank Kung works for Revance
Frank Kung's role in Revance is Director
Frank Kung works in the industry of Biotechnology Research
Frank Kung's colleagues are Frank Kung,Ronni H.,Taryn Conway
Frank Kung's latest job experience is Director at Revance
Frank Kung's latest education in National Tsing Hua University